StockTipsArenaBeta

BUY Laurus Labs Ltd — Ansh Jogendra Bhilwar

BUYLaurus Labs Ltd
Laurus Labs share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: 1 year28 Oct 2026via Zee Business (Live)

Entry₹2,142Inferred
Target₹2,415
Total upside +12.75%
Stop loss₹2,009-6.21% risk
CMP₹2,181.97h ago
Active+1.86%+10.68%upside left 12 mo left
Follow Ansh Jogendra Bhilwar for new calls(26% target hit, 27 closed calls)Get alertsWatch LAURUSLABS for new buy/sell callsGet alertsSee 5 other Long-term calls on LAURUSLABSSee 200 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 28 Oct, 11:36 pm IST
14 supporting7 neutral1 opposing
Supports the BUY call (14)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·28 Oct · today

Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside

NewsEt-Markets·16 Oct · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·16 Oct · 2w ago

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·16 Oct · 2w ago

Neutral / worth noting (7)

Q2 FY27 results scheduled — board meets 29 Oct 2026

BSE · Board Meeting·29 Oct · today

(opens in new tab)

Laurus Labs invested INR 1.078 billion in its joint venture KRKA Pharma Private Limited via a rights issue, maintaining its 49% stake.

BSE · Company Update·14 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

2 other SEBI-registered advisors have active long-term SELL calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·28 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Laurus Labs

All analyst calls on Laurus Labs

More from Ansh Jogendra Bhilwar

Every call and its outcome